Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more.
Category: Pancreas
-
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Many
The New York Times – Business: -
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
The New York Times – Business:In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
-
How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough
The New York Times – Business:The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.
-
F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer
The New York Times – Business:Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.
-
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
The New York Times – Business:In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.